Skip to main content

Emmaus Life Sciences, Inc.

EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0000822370

In the last 90 days, Emmaus Life Sciences, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Insider buysLast 90 days, $18.1K in total
1
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding EMMA, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding EMMA at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Emmaus Life Sciences, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 2, 2026 (view filing)3:05 PM ETMay 30, 2025-Aug 31, 2026460 daysLateLee Willis CCEOPPurchaseCommon stock, $0.001 par value+530.8K$0.0342+$18.1K+333.0%690.2K after6 lots
Sep 18, 2024 (view filing)11:40 AM ETSep 162 daysLim Seah H.DirectorPPurchaseCommon stock, $0.001 par value+20.0K$0.04+$800+0.4%4.61M after
Feb 29, 2024 (view filing)6:11 PM ETFeb 26-293 daysLateLee Willis CCo-President & COOPPurchaseCommon stock, $0.001 par value+115.2K$0.1276+$14.7K+260.6%159.4K after4 lots
Jan 3, 2024 (view filing)4:59 PM ETAug 25-Nov 14, 2023131 daysLee Willis CCOOPPurchaseCommon stock, $0.001 par value+13.6K$0.1763+$2.40K+44.4%44.2K afterAmended3 lots
Jan 3, 2024 (view filing)4:59 PM ETNov 28-30, 202336 daysLee Willis CCOOPPurchaseCommon stock, $0.001 par value+107.4K$0.12+$12.9K+37.3%395.1K afterAmended3 lots
Dec 21, 2023 (view filing)11:34 AM ETDec 201 dayLim Seah H.DirectorSSaleCommon stock, $0.001 par value−32.5K$0.05−$1.63K−0.7%4.59M after
Dec 19, 2023 (view filing)7:44 PM ETOct 9, 2022-Sep 5, 2023436 daysLateLim Seah H.DirectorPPurchaseCommon stock, $0.001 par value+139.2K$0.2221+$30.9K+361.6%177.7K after4 lots
Dec 19, 2023 (view filing)7:44 PM ETDec 154 daysLim Seah H.DirectorSSaleCommon stock, $0.001 par value−6.00K$0.11−$660−3.4%171.7K after
Jun 2, 2023 (view filing)1:23 PM ETSep 20, 2022255 daysLateLee Willis CCOOPPurchaseCommon stock, $0.001 par value+750$0.28+$210+0.3%287.7K after
Jun 2, 2023 (view filing)1:23 PM ETMay 312 daysLee Willis CCOOPPurchaseCommon stock, $0.001 par value+28.7K$0.29+$8.32K+1,510.5%30.6K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Emmaus Life Sciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding EMMA in 13F filings for Q2 2026.